The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Avian Influenza Vaccines market size is estimated to be worth US$ 976.5 million in 2021 and is forecast to a readjusted size of USD 1398.3 million by 2028 with a CAGR of 5.3% during review period. Chicken Avian Influenza Vaccines accounting for % of the Avian Influenza Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While H5+H7 Avian Influenza Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Avian Influenza Vaccines include Merial, QYH Biotech, DHN, HVRI, and CEVA, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Avian Influenza Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Market segment by Application can be divided into
Chicken Avian Influenza Vaccines
Duck & Goose Avian Influenza Vaccines
Other
The key market players for global Avian Influenza Vaccines market are listed below:
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco (Lohmann )
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
Medion
Avimex Animal Health
JOVAC
Bio-Labs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Avian Influenza Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Avian Influenza Vaccines, with price, sales, revenue and global market share of Avian Influenza Vaccines from 2019 to 2022.
Chapter 3, the Avian Influenza Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Avian Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Avian Influenza Vaccines.
Chapter 13, 14, and 15, to describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Avian Influenza Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Avian Influenza Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Avian Influenza Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chicken Avian Influenza Vaccines
1.3.3 Duck & Goose Avian Influenza Vaccines
1.3.4 Other
1.4 Global Avian Influenza Vaccines Market Size & Forecast
1.4.1 Global Avian Influenza Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Avian Influenza Vaccines Sales in Volume (2017-2028)
1.4.3 Global Avian Influenza Vaccines Price (2017-2028)
1.5 Global Avian Influenza Vaccines Production Capacity Analysis
1.5.1 Global Avian Influenza Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Avian Influenza Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Avian Influenza Vaccines Market Drivers
1.6.2 Avian Influenza Vaccines Market Restraints
1.6.3 Avian Influenza Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business
2.1.3 Merial Avian Influenza Vaccines Product and Services
2.1.4 Merial Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 QYH Biotech
2.2.1 QYH Biotech Details
2.2.2 QYH Biotech Major Business
2.2.3 QYH Biotech Avian Influenza Vaccines Product and Services
2.2.4 QYH Biotech Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 DHN
2.3.1 DHN Details
2.3.2 DHN Major Business
2.3.3 DHN Avian Influenza Vaccines Product and Services
2.3.4 DHN Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 HVRI
2.4.1 HVRI Details
2.4.2 HVRI Major Business
2.4.3 HVRI Avian Influenza Vaccines Product and Services
2.4.4 HVRI Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CEVA
2.5.1 CEVA Details
2.5.2 CEVA Major Business
2.5.3 CEVA Avian Influenza Vaccines Product and Services
2.5.4 CEVA Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Elanco (Lohmann )
2.6.1 Elanco (Lohmann ) Details
2.6.2 Elanco (Lohmann ) Major Business
2.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Product and Services
2.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Yebio
2.7.1 Yebio Details
2.7.2 Yebio Major Business
2.7.3 Yebio Avian Influenza Vaccines Product and Services
2.7.4 Yebio Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zoetis
2.8.1 Zoetis Details
2.8.2 Zoetis Major Business
2.8.3 Zoetis Avian Influenza Vaccines Product and Services
2.8.4 Zoetis Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 FATRO
2.9.1 FATRO Details
2.9.2 FATRO Major Business
2.9.3 FATRO Avian Influenza Vaccines Product and Services
2.9.4 FATRO Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Kyoto Biken
2.10.1 Kyoto Biken Details
2.10.2 Kyoto Biken Major Business
2.10.3 Kyoto Biken Avian Influenza Vaccines Product and Services
2.10.4 Kyoto Biken Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 CAVAC
2.11.1 CAVAC Details
2.11.2 CAVAC Major Business
2.11.3 CAVAC Avian Influenza Vaccines Product and Services
2.11.4 CAVAC Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ringpu Biology
2.12.1 Ringpu Biology Details
2.12.2 Ringpu Biology Major Business
2.12.3 Ringpu Biology Avian Influenza Vaccines Product and Services
2.12.4 Ringpu Biology Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Vaksindo
2.13.1 Vaksindo Details
2.13.2 Vaksindo Major Business
2.13.3 Vaksindo Avian Influenza Vaccines Product and Services
2.13.4 Vaksindo Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 ChengDu Tecbond
2.14.1 ChengDu Tecbond Details
2.14.2 ChengDu Tecbond Major Business
2.14.3 ChengDu Tecbond Avian Influenza Vaccines Product and Services
2.14.4 ChengDu Tecbond Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Sindh Poultry Vaccine Centre
2.15.1 Sindh Poultry Vaccine Centre Details
2.15.2 Sindh Poultry Vaccine Centre Major Business
2.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
2.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Merck Animal Health
2.16.1 Merck Animal Health Details
2.16.2 Merck Animal Health Major Business
2.16.3 Merck Animal Health Avian Influenza Vaccines Product and Services
2.16.4 Merck Animal Health Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Medion
2.17.1 Medion Details
2.17.2 Medion Major Business
2.17.3 Medion Avian Influenza Vaccines Product and Services
2.17.4 Medion Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Avimex Animal Health
2.18.1 Avimex Animal Health Details
2.18.2 Avimex Animal Health Major Business
2.18.3 Avimex Animal Health Avian Influenza Vaccines Product and Services
2.18.4 Avimex Animal Health Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 JOVAC
2.19.1 JOVAC Details
2.19.2 JOVAC Major Business
2.19.3 JOVAC Avian Influenza Vaccines Product and Services
2.19.4 JOVAC Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Bio-Labs
2.20.1 Bio-Labs Details
2.20.2 Bio-Labs Major Business
2.20.3 Bio-Labs Avian Influenza Vaccines Product and Services
2.20.4 Bio-Labs Avian Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Avian Influenza Vaccines Breakdown Data by Manufacturer
3.1 Global Avian Influenza Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Avian Influenza Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Avian Influenza Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Avian Influenza Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Avian Influenza Vaccines Manufacturer Market Share in 2021
3.5 Global Avian Influenza Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Avian Influenza Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Avian Influenza Vaccines Market Size by Region
4.1.1 Global Avian Influenza Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Avian Influenza Vaccines Revenue by Region (2017-2028)
4.2 North America Avian Influenza Vaccines Revenue (2017-2028)
4.3 Europe Avian Influenza Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Avian Influenza Vaccines Revenue (2017-2028)
4.5 South America Avian Influenza Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Avian Influenza Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Avian Influenza Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Avian Influenza Vaccines Revenue by Type (2017-2028)
5.3 Global Avian Influenza Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Avian Influenza Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Avian Influenza Vaccines Revenue by Application (2017-2028)
6.3 Global Avian Influenza Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Avian Influenza Vaccines Sales by Type (2017-2028)
7.2 North America Avian Influenza Vaccines Sales by Application (2017-2028)
7.3 North America Avian Influenza Vaccines Market Size by Country
7.3.1 North America Avian Influenza Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Avian Influenza Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Avian Influenza Vaccines Sales by Type (2017-2028)
8.2 Europe Avian Influenza Vaccines Sales by Application (2017-2028)
8.3 Europe Avian Influenza Vaccines Market Size by Country
8.3.1 Europe Avian Influenza Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Avian Influenza Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Avian Influenza Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Avian Influenza Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Avian Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Avian Influenza Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Avian Influenza Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Avian Influenza Vaccines Sales by Type (2017-2028)
10.2 South America Avian Influenza Vaccines Sales by Application (2017-2028)
10.3 South America Avian Influenza Vaccines Market Size by Country
10.3.1 South America Avian Influenza Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Avian Influenza Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Avian Influenza Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Avian Influenza Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Avian Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Avian Influenza Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Avian Influenza Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Avian Influenza Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Avian Influenza Vaccines
12.3 Avian Influenza Vaccines Production Process
12.4 Avian Influenza Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Avian Influenza Vaccines Typical Distributors
13.3 Avian Influenza Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Avian Influenza Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merial Basic Information, Manufacturing Base and Competitors
Table 4. Merial Major Business
Table 5. Merial Avian Influenza Vaccines Product and Services
Table 6. Merial Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 8. QYH Biotech Major Business
Table 9. QYH Biotech Avian Influenza Vaccines Product and Services
Table 10. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. DHN Basic Information, Manufacturing Base and Competitors
Table 12. DHN Major Business
Table 13. DHN Avian Influenza Vaccines Product and Services
Table 14. DHN Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. HVRI Basic Information, Manufacturing Base and Competitors
Table 16. HVRI Major Business
Table 17. HVRI Avian Influenza Vaccines Product and Services
Table 18. HVRI Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CEVA Basic Information, Manufacturing Base and Competitors
Table 20. CEVA Major Business
Table 21. CEVA Avian Influenza Vaccines Product and Services
Table 22. CEVA Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Elanco (Lohmann ) Basic Information, Manufacturing Base and Competitors
Table 24. Elanco (Lohmann ) Major Business
Table 25. Elanco (Lohmann ) Avian Influenza Vaccines Product and Services
Table 26. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Yebio Basic Information, Manufacturing Base and Competitors
Table 28. Yebio Major Business
Table 29. Yebio Avian Influenza Vaccines Product and Services
Table 30. Yebio Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zoetis Basic Information, Manufacturing Base and Competitors
Table 32. Zoetis Major Business
Table 33. Zoetis Avian Influenza Vaccines Product and Services
Table 34. Zoetis Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. FATRO Basic Information, Manufacturing Base and Competitors
Table 36. FATRO Major Business
Table 37. FATRO Avian Influenza Vaccines Product and Services
Table 38. FATRO Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Kyoto Biken Basic Information, Manufacturing Base and Competitors
Table 40. Kyoto Biken Major Business
Table 41. Kyoto Biken Avian Influenza Vaccines Product and Services
Table 42. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. CAVAC Basic Information, Manufacturing Base and Competitors
Table 44. CAVAC Major Business
Table 45. CAVAC Avian Influenza Vaccines Product and Services
Table 46. CAVAC Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 48. Ringpu Biology Major Business
Table 49. Ringpu Biology Avian Influenza Vaccines Product and Services
Table 50. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 52. Vaksindo Major Business
Table 53. Vaksindo Avian Influenza Vaccines Product and Services
Table 54. Vaksindo Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 56. ChengDu Tecbond Major Business
Table 57. ChengDu Tecbond Avian Influenza Vaccines Product and Services
Table 58. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Sindh Poultry Vaccine Centre Basic Information, Manufacturing Base and Competitors
Table 60. Sindh Poultry Vaccine Centre Major Business
Table 61. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
Table 62. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 64. Merck Animal Health Major Business
Table 65. Merck Animal Health Avian Influenza Vaccines Product and Services
Table 66. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Medion Basic Information, Manufacturing Base and Competitors
Table 68. Medion Major Business
Table 69. Medion Avian Influenza Vaccines Product and Services
Table 70. Medion Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Avimex Animal Health Basic Information, Manufacturing Base and Competitors
Table 72. Avimex Animal Health Major Business
Table 73. Avimex Animal Health Avian Influenza Vaccines Product and Services
Table 74. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. JOVAC Basic Information, Manufacturing Base and Competitors
Table 76. JOVAC Major Business
Table 77. JOVAC Avian Influenza Vaccines Product and Services
Table 78. JOVAC Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Bio-Labs Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Labs Major Business
Table 81. Bio-Labs Avian Influenza Vaccines Product and Services
Table 82. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Avian Influenza Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 84. Global Avian Influenza Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Avian Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Avian Influenza Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 87. Head Office and Avian Influenza Vaccines Production Site of Key Manufacturer
Table 88. Avian Influenza Vaccines New Entrant and Capacity Expansion Plans
Table 89. Avian Influenza Vaccines Mergers & Acquisitions in the Past Five Years
Table 90. Global Avian Influenza Vaccines Sales by Region (2017-2022) & (M Doses)
Table 91. Global Avian Influenza Vaccines Sales by Region (2023-2028) & (M Doses)
Table 92. Global Avian Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Avian Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 95. Global Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 96. Global Avian Influenza Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Avian Influenza Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Avian Influenza Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 99. Global Avian Influenza Vaccines Price by Type (2023-2028) & (USD/K Doses)
Table 100. Global Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 101. Global Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 102. Global Avian Influenza Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Avian Influenza Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Avian Influenza Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 105. Global Avian Influenza Vaccines Price by Application (2023-2028) & (USD/K Doses)
Table 106. North America Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 107. North America Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 108. North America Avian Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Avian Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 111. North America Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 112. North America Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 113. North America Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 114. Europe Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 115. Europe Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 116. Europe Avian Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Avian Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 119. Europe Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 120. Europe Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 121. Europe Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 122. Asia-Pacific Avian Influenza Vaccines Sales by Region (2017-2022) & (M Doses)
Table 123. Asia-Pacific Avian Influenza Vaccines Sales by Region (2023-2028) & (M Doses)
Table 124. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 127. Asia-Pacific Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 128. Asia-Pacific Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 129. Asia-Pacific Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 130. South America Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 131. South America Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 132. South America Avian Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Avian Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 135. South America Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 136. South America Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 137. South America Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 138. Middle East & Africa Avian Influenza Vaccines Sales by Region (2017-2022) & (M Doses)
Table 139. Middle East & Africa Avian Influenza Vaccines Sales by Region (2023-2028) & (M Doses)
Table 140. Middle East & Africa Avian Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Avian Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 143. Middle East & Africa Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 144. Middle East & Africa Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 145. Middle East & Africa Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 146. Avian Influenza Vaccines Raw Material
Table 147. Key Manufacturers of Avian Influenza Vaccines Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Avian Influenza Vaccines Typical Distributors
Table 151. Avian Influenza Vaccines Typical Customers
List of Figures
Figure 1. Avian Influenza Vaccines Picture
Figure 2. Global Avian Influenza Vaccines Revenue Market Share by Type in 2021
Figure 3. H5+H7 Avian Influenza Vaccines
Figure 4. H9 Avian Influenza Vaccines
Figure 5. Global Avian Influenza Vaccines Revenue Market Share by Application in 2021
Figure 6. Chicken Avian Influenza Vaccines
Figure 7. Duck & Goose Avian Influenza Vaccines
Figure 8. Other
Figure 9. Global Avian Influenza Vaccines Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 10. Global Avian Influenza Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Avian Influenza Vaccines Sales (2017-2028) & (M Doses)
Figure 12. Global Avian Influenza Vaccines Price (2017-2028) & (USD/K Doses)
Figure 13. Global Avian Influenza Vaccines Production Capacity (2017-2028) & (M Doses)
Figure 14. Global Avian Influenza Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Avian Influenza Vaccines Market Drivers
Figure 16. Avian Influenza Vaccines Market Restraints
Figure 17. Avian Influenza Vaccines Market Trends
Figure 18. Global Avian Influenza Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Avian Influenza Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Avian Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Avian Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Avian Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Avian Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Avian Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Avian Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Avian Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Avian Influenza Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Avian Influenza Vaccines Price by Type (2017-2028) & (USD/K Doses)
Figure 33. Global Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Avian Influenza Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Avian Influenza Vaccines Price by Application (2017-2028) & (USD/K Doses)
Figure 36. North America Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Avian Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Avian Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Avian Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Avian Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Avian Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Avian Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Avian Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Avian Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 78. Avian Influenza Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source